.svg){kind=small}
Aug-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
High Falls Canna New York is stocked at 80 licensed dispensaries across New York, with the deepest coverage in New York, Queens, Albany, Staten Island, and Binghamton. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
In August 2026, High Falls Canna New York’s mix tilted heavily toward Flower at 57.51% share, even as Flower declined both year over year by 5.65% and month over month by 11.83%, while Pre-Roll expanded to 24.37% share with a 58.20% YoY gain and 29.10% MoM growth. Concentrates, though only 7.59% share, posted a 309.94% YoY increase and 10.30% MoM rise, contrasting with Tincture & Sublingual at 9.70% share falling 43.20% YoY and 11.60% MoM; the steep contractions in Edible (−93.89% YoY, −2.31% MoM) and a smaller Topical rebound (+17.30% MoM, −72.87% YoY) frame a portfolio migrating away from wellness-adjacent formats. With brand sales down 4.50% YoY and average price down 20.32% YoY to $22.21, the mix shift toward faster-growing Pre-Roll and Concentrates alongside a weakening Flower base implies a volume-chasing strategy that compensates for price compression in New York.
The month’s mix suggests repositioning from a Flower-led identity toward an accessibly priced inhalables portfolio, as rising Pre-Roll share (+29.10% MoM) and Concentrates growth (+10.30% MoM) coincide with a double-digit MoM pullback in Flower (−11.83%) and Tincture & Sublingual (−11.60%). Holding a Flower category rank of 54 in New York while the category remains over half of sales (57.51%) creates a ceiling on brand momentum, whereas outsized YoY growth in Concentrates (+309.94%) and Pre-Roll (+58.20%) indicates clearer headroom if the portfolio continues reallocating shelf focus. Net, the data implies that near-term share gains are more attainable by leaning into Pre-Roll and Concentrates while actively managing Flower price architecture to stabilize rank at 54 and mitigate further YoY contraction.
Competitive Landscape
High Falls Canna New York sits at rank #54 in NY Flower for August 2026, slipping 2 spots year over year from #52 while also dropping 3 positions since May 2026 from #51, and it is far removed from its peak of #29 reached in August 2024. In contrast, Find. advanced from #6 to #1 with a 30.3% YoY sales increase, and Grassroots moved from #14 to #4 alongside an 88.4% YoY sales gain, while Rolling Green Cannabis slid from #2 to #5 amid a 36.1% YoY sales decline. The combination of a 2-rank YoY dip and a multi-year fall from #29 to #54 implies that High Falls Canna New York is losing relative velocity as faster-rising incumbents consolidate the top tier.
Notable Products
Dynamic Doob - Hybrid Kief Infused Pre-Roll 2-Pack (1g) posted the largest month-over-month gain at +52.8%, climbing to rank 4 while OG Kush Pre-Roll 2-Pack (1g) rose +41.7% at rank 3. Indica Blend Pre-Roll 2-Pack (1g) advanced +20.4% to hold rank 1, and Sativa Blend Pre-Roll 2-Pack (1g) jumped +42.1% to rank 2. With five of the top six items in Pre-Roll and three of the top five delivering 20%+ to 52%+ gains, the mix implies a pivot toward fast-turn inhalables where velocity is concentrating at the top ranks.
Killer Queen HV (3.5g) in Flower increased +25.7% to rank 7, while Sunset Sherbert (3.5g) entered the top ten at rank 8 without a reported prior-month rate. G13 (14g) held rank 10 with $32,819 in sales, and Dynamic Doob Pre-Roll 2-Pack (1g) landed at rank 9 despite no month-over-month figure. The pattern implies Flower is stabilizing in mid-table positions while Pre-Roll momentum draws share upward, signaling resource allocation toward duo-pack and infused formats.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
